Relationship between biochemical markers and radiographic scores in the evaluation of the osteoarticular status of Warmblood stallions

Research in Veterinary Science

Volumn 87, Issue 2, 2009, Pages 319-328

  Verwilghen, Denis ^a   Busoni, Valeria ^a   Gangl, Monika ^c   Franck, Thierry ^a   Lejeune, Jean Philippe ^b   Vanderheyden, Laurent ^b   Detilleux, Johann ^a   Grulke, Sigrid ^a   Deberg, Michelle ^a   Henrotin, Yves ^a   Serteyn, Didier ^a,b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b European Horse Centre   (Belgium)

^c VETAGRO SUP   (France)

Author keywords

Biochemical markers; Collagen degradation; Horse; Insulin growth factor I; Myeloperoxidases; Radiological scoring

Indexed keywords

BIOCHEMICAL MARKER; COLLAGEN TYPE 2; MYELOPEROXIDASE; SOMATOMEDIN C;

ANIMAL LAMENESS; ARTICLE; BONE RADIOGRAPHY; CARTILAGE DEGENERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; HORSE DISEASE; INTERPHALANGEAL JOINT; JOINT EFFUSION; MALE; NONHUMAN; OSTEOARTHRITIS; OSTEOCHONDROSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SCORING SYSTEM; STALLION; SYNOVITIS;

ANIMALS; BIOLOGICAL MARKERS; BONE AND BONES; HORSE DISEASES; HORSES; JOINT DISEASES; JOINTS; MALE; OSTEOCHONDROSIS; RADIOGRAPHY;

ANIMALIA; EQUIDAE;

EID: 67650617760     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rvsc.2009.02.002     Document Type: Article

References (54)

1. Art T., Franck T., Gangl M., Votion D., Kohnen S., Deby-Dupont G., and Serteyn D. Plasma concentrations of myeloperoxidase in endurance and 3-day event horses after a competition. Equine Veterinary Journal Supplement (2006) 298-302
2. Art T., Franck T., Lekeux P., de Moffarts B., Couetil L., Becker M., Kohnen S., Deby-Dupont G., and Serteyn D. Myeloperoxidase concentration in bronchoalveolar lavage fluid from healthy horses and those with recurrent airway obstruction. Canadian Journal of Veterinary Research 70 (2006) 291-296
3. Baldus S., Eiserich J.P., Brennan M.L., Jackson R.M., Alexander C.B., and Freeman B.A. Spatial mapping of pulmonary and vascular nitrotyrosine reveals the pivotal role of myeloperoxidase as a catalyst for tyrosine nitration in inflammatory diseases. Free Radical Biology and Medicine 33 (2002) 1010-1019
4. Beckman J.S., and Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. American Journal of Physiology-Cell Physiology 40 (1996) C1424-C1437
5. Billinghurst R.C., Brama P.A., van Weeren P.R., Knowlton M.S., and McIlwraith C.W. Evaluation of serum concentrations of biomarkers of skeletal metabolism and results of radiography as indicators of severity of osteochondrosis in foals. American Journal of Veterinary Research 65 (2004) 143-150
6. Billinghurst R.C., Dahlberg L., Ionescu M., Reiner A., Bourne R., Rorabeck C., Mitchell P., Hambor J., Diekmann O., Tschesche H., Chen J., Van Wart H., and Poole A.R. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. Journal of Clinical Investigation 99 (1997) 1534-1545
7. Brennan M.L., Wu W.J., Fu X.M., Shen Z.Z., Song W., Frost H., Vadseth C., Narine L., Lenkiewicz E., Borchers M.T., Lusis A.J., Lee J.J., Lee N.A., Abu-Soud H.M., Ischiropoulos H., and Hazen S.L. A tale of two controversies - defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species. Journal of Biological Chemistry 277 (2002) 17415-17427
8. Burner U., Furtmuller P.G., Kettle A.J., Koppenol W.H., and Obinger C. Mechanism of reaction of myeloperoxidase with nitrite. Journal of Biological Chemistry 275 (2000) 20597-20601
9. Courouce-Malblanc A., Leleu C., Bouchilloux M., and Geffroy O. Abnormal radiographic findings in 865 French standardbred trotters and their relationship to racing performance. Equine Veterinary Journal Supplement (2006) 417-422
10. Davicco M.J., Faulconnier Y., Coxam V., Dubroeucq H., Martin-Rosset W., and Barlet J.P. Systemic bone growth factors in light breed mares and their foals. Archives Internationales de Physiologie, de Biochimie et de Biophysique 102 (1994) 115-119
11. 2 and myeloperoxydase serum levels in oa patients after hip or knee replacement. Annals of the Rheumatic Diseases 67 (2008) 168-174
12. 2) for studying oxidative-related type II collagen network degradation in patients with osteoarthritis and rheumatoid arthritis. Osteoarthritis and Cartilage 13 (2005) 258-265
13. Dik K.J., Enzerink E., and van Weeren P.R. Radiographic development of osteochondral abnormalities, in the hock and stifle of Dutch Warmblood foals, from age 1 to 11 months. Equine Veterinary Journal Supplement 31 (1999) 9-15
14. Donabedian M., van Weeren P.R., Perona G., Fleurance G., Robert C., Leger S., Bergero D., Lepage O., and Martin-Rosset W. Early changes in biomarkers of skeletal metabolism and their association to the occurrence of osteochondrosis (OC) in the horse. Equine Veterinary Journal 40 (2008) 253-259
15. Fortier L.A., Balkman C.E., Sandell L.J., Ratcliffe A., and Nixon A.J. Insulin-like growth factor-I gene expression patterns during spontaneous repair of acute articular cartilage injury. Journal of Orthopaedic Research 19 (2001) 720-728
16. Franck T., Grulke S., Deby-Dupont G., Deby C., Duvivier H., Peters F., and Serteyn D. Development of an enzyme-linked immunosorbent assay for specific equine neutrophil myeloperoxidase measurement in blood. Journal of Veterinary Diagnostic Investigation 17 (2005) 412-419
17. Gangl, M., Franck, T., Lejeune, J., Vanderheyden, L., Grulke, S., Verwilghen, D., Deberg, M., Henrotin, Y., Serteyn, D., 2008. Variations plasmatiques de quatre marqueurs du métabolisme cartilagineux et de l'inflammation chez les chevaux atteints d'ostéochondrose. 34ème journée de la recherche équine, Paris, pp. 87-93.
18. Gangl M., Serteyn D., Lejeun J.P., Schneider N., Grulke S., Peters F., Vila T., Deby-Dupont G., Deberg M., and Henrotin Y. A type II-collagen derived peptide and its nitrated form as new markers of inflammation and cartilage degradation in equine osteochondral lesions. Research in Veterinary Science 82 (2007) 68-75
19. Gaut J.P., Byun J., Tran H.D., Lauber W.M., Carroll J.A., Hotchkiss R.S., Belaaouaj A., and Heinecke J.W. Myeloperoxidase produces nitrating oxidants in vivo. Journal of Clinical Investigation 109 (2002) 1311-1319
20. Grondahl A.M. The incidence of osteochondrosis in the tibiotarsal joint of norwegian standard-bred trotters - a radiographic study. Journal of Equine Veterinary Science 11 (1991) 272-274
21. Grondahl A.M. The incidence of bony fragments and osteochondrosis in the metacarpophalangeal and metatarsophalangeal joints of standard-bred trotters - a radiographic study. Journal of Equine Veterinary Science 12 (1992) 81-85
22. Grulke S., Benbarek H., Caudron I., Deby-Dupont G., Mathy-Hartert M., Farnir F., Deby C., Lamy M., and Serteyn D. Plasma myeloperoxidase level and polymorphonuclear leukocyte activation in horses suffering from large intestinal obstruction requiring surgery: preliminary results. Canadian Journal of Veterinary Research 63 (1999) 142-147
23. Henrotin Y., Addison S., Kraus V., and Deberg M. Type II collagen markers in osteoarthritis: what do they indicate?. Current Opinion in Rheumatology 19 (2007) 444-450
24. Henrotin Y., Deberg M., Dubuc J.E., Quettier E., Christgau S., and Reginster J.Y. Type II collagen peptides for measuring cartilage degradation. Biorheology 41 (2004) 543-547
25. Henrotin Y., Debydupont G., Deby C., Debruyn M., Lamy M., and Franchimont P. Production of active oxygen species by isolated human chondrocytes. British Journal of Rheumatology 32 (1993) 562-567
26. Henrotin Y.E., Zheng S.X., Deby G.P., Labasse A.H., Crielaard J.M.R., and Reginster J.Y.L. Nitric oxide downregulates interleukin 1 beta (IL-1 beta) stimulated IL-6, IL-8, and prostaglandin E-2 production by human chondrocytes. Journal of Rheumatology 25 (1998) 1595-1601
27. Jackson B.F., Blumsohn A., Goodship A.E., Wilson A.M., and Price J.S. Circadian variation in biochemical markers of bone cell activity and insulin-like growth factor-I in two-year-old horses. Journal of Animal Science 81 (2003) 2804-2810
28. Jackson B.F., Goodship A.E., Eastell R., and Price J.S. Evaluation of serum concentrations of biochemical markers of bone metabolism and insulin-like growth factor I associated with treadmill exercise in young horses. American Journal of Veterinary Research 64 (2003) 1549-1556
29. Jeffcott L.B. Osteochondrosis in the horse - searching for the key to pathogenesis. Equine Veterinary Journal 23 (1991) 331-338
30. Jeffcott L.B. Osteochondrosis - an international problem for the horse industry. Journal of Equine Veterinary Science 16 (1996) 32-37
31. Kane A.J., Park R.D., McIlwraith C.W., Rantanen N.W., Morehead J.P., and Bramlage L.R. Radiographic changes in thoroughbred yearlings. Part 1: prevalence at the time of the yearling sales. Equine Veterinary Journal 35 (2003) 354-365
32. Kaur H., and Halliwell B. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation - nitrotyrosine in serum and synovial-fluid from rheumatoid patients. FEBS Letters 350 (1994) 9-12
33. Kuwabara K., Jyoyama H., Fleisch J.H., and Hori Y. Inhibition of antigen-induced arthritis in guinea pigs by a selective LTB4 receptor antagonist LY293111Na. Inflammation Research 51 (2002) 541-550
34. Laverty S., Okouneff S., Ionescu M., Reiner A., Pidoux I., Webber C., Rossier Y., Billinghurst R.C., and Poole A.R. Excessive degradation of type II collagen in articular cartilage in equine osteochondrosis. Journal of Orthopaedic Research 20 (2002) 1282-1289
35. Lejeune J.P., Franck T., Gangl M., Schneider N., Michaux C., Deby-Dupont G., and Serteyn D. Plasma concentration of insulin-like growth factor I (IGF-I) in growing Ardenner horses suffering from juvenile digital degenerative osteoarthropathy. Veterinary Research Communications 31 (2007) 185-195
36. Lejeune J.P., Serteyn D., Gangl M., Schneider N., Deby-Dupont G., Deberg M., and Henrotin Y. Plasma concentrations of a type II collagen-derived peptide and its nitrated form in growing ardenner sound horses and in horses suffering from juvenile digital degenerative osteoarthropathy. Veterinary Research Communications 31 (2007) 591-601
37. O'Kane J.W., Hutchinson E., Atley L.M., and Eyre D.R. Sport-related differences in biomarkers of bone resorption and cartilage degradation in endurance athletes. Osteoarthritis and Cartilage 14 (2006) 71-76
38. Olivier A., Nurton J.P., and Guthrie A.J. An epizoological study of wastage in thoroughbred racehorses in Gauteng, South Africa. Journal of the South African Veterinary Association 68 (1997) 125-129
39. Philipsson J., Andréasson E., Sandgren B., Dalin G., and Carlsten J. Osteochondrosis in the tarsocrural joint and osteochondral fragments in the fetlock joints in standardbred trotters II. Heritability. Equine Veterinary Journal Supplement 16 (1993) 38-41
40. Robert C., Valette J.P., and Denoix J.M. Correlation between routine radiographic findings and early racing career in French trotters. Equine Veterinary Journal Supplement (2006) 473-478
41. Rossdale P.D., Hopes R., Digby N.J., and offord K. Epidemiological study of wastage among racehorses 1982 and 1983. Veterinary Record 116 (1985) 66-69
42. Schneider N., Mouithys-Mickalad A.L., Lejeune J.P., Deby-Dupont G.P., Hoebeke M., and Serteyn D.A. Synoviocytes, not chondrocytes, release free radicals after cycles of anoxia/re-oxygenation. Biochemical and Biophysical Research Communications 334 (2005) 669-673
43. Semevolos S.A., Nixon A.J., and Brower-Toland B.D. Changes in molecular expression of aggrecan and collagen types I, II, and X, insulin-like growth factor-I, and transforming growth factor-beta 1 in articular cartilage obtained from horses with naturally acquired osteochondrosis. American Journal of Veterinary Research 62 (2001) 1088-1094
44. Semevolos, S.A., Nixon, A.J., Strassheim, L., 2004. Unlocking the key to equine articular osteochondrosis: The role of molecular regulators. AAEP Focus on Joints. Louisville, Kentucky, pp. 98-102.
45. Serteyn D., Grulke S., Franck T., Mouithys-Mickalad A., and Deby-Dupont G. Neutrophile myeloperoxidase, protective enzyme with strong oxidative activities. Annales de Medecine Veterinaire 147 (2003) 79-93
46. Skioldebrand E., Heinegard D., Olofsson B., Rucklidge G., Roneus N., and Ekman S. Altered homeostasis of extracellular matrix proteins in joints of standardbred trotters during a long-term training programme. Journal of Veterinary Medicine. A, Physiology, Pathology, Clinical Medicine 53 (2006) 445-449
47. Sloet van Oldenruitenborgh-Oosterbaan M.M., Mol J.A., and Barneveld A. Hormones, growth factors and other plasma variables in relation to osteochondrosis. Equine Veterinary Journal Supplement 31 (1999) 45-54
48. Stock K.F., Hamann H., and Distl O. Prevalence of osseous fragments in distal and proximal interphalangeal, metacarpo- and metatarsophalangeal and tarsocrural joints of Hanoverian Warmblood horses. Journal of Veterinary Medicine. A, Physiology, Pathology, Clinical Medicine 52 (2005) 388-394
49. Stock K.F., Meiners F., Hamann H., and Distl O. Analysis of the distribution of radiographic findings among Hanoverian Warmblood horses selected for sale by auction. Part 1: osseous fragments in different limb joints. Tierarztliche Praxis Ausgabe Grosstiere Nutztiere 32 (2004) 157-168
50. Thorp B.H., Ekman S., Jakowlew S.B., and Goddard C. Porcine osteochondrosis: deficiencies in transforming growth factor-beta and insulin-like growth factor-I. Calcified Tissue International 56 (1995) 376-381
51. Todhunter R.J., and Lust G. Pathophysiology of synovitis - clinical signs and examination in horses. Compendium on Continuing Education for the Practicing Veterinarian 12 (1990) 980-992
52. van Hoogmoed L.M., Snyder J.R., Thomas H.L., and Harmon F.A. Retrospective evaluation of equine prepurchase examinations performed 1991-2000. Equine Veterinary Journal 35 (2003) 375-381
53. Wittwer C., Hamann H., Rosenberger E., and Distl O. Prevalence of osteochondrosis in the limb joints of south German coldblood horses. Journal of Veterinary Medicine. A, Physiology, Pathology, Clinical Medicine 53 (2006) 531-539
54. Zofkova I. Pathophysiological and clinical importance of insulin-like growth factor-I with respect to bone metabolism. Physiological Research 52 (2003) 657-679